Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRRK · against 225 other Healthcare companies of similar size
Ranked #216 of 226 · scores higher than 4% of peers
Bars: peers in each 10-point band of the profitability score13 peers with a profitability score of 0–9, including SRRK · Click a bar to see the companies
Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | SRRK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 217 reported | -2489.4% | 8.2% | 0% | 33% | |
| Operating marginHigher is better · 206 reported | Not reported | 10.7% | — | — | 33% |
| Return on assetsHigher is better · 216 reported | -78.1% | 3.3% | 2% | 33% | |
| Return on equityHigher is better · 211 reported | -167.8% | 7.5% | 4% | Context only | |
| Gross marginHigher is better · 234 reported | 0.0% | 49.3% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 210 | 8.8B USD | 10 | 31 | |
| 210 | 3.0B USD | 10 | 11 | |
| 214 | 7.7B USD | 9 | 36 | |
| 214 | 3.3B USD | 9 | 39 | |
| 216 | 5.4B USD | 8 | 24 | |
| 217 | 2.8B USD | 7 | 51 | |
| 218 | 5.7B USD | 5 | 52 | |
| 218 | 4.8B USD | 5 | 27 | |
| 218 | 4.6B USD | 5 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score